Luliconazole
- Generic Name
- Luliconazole
- Brand Names
- Luzu
- Drug Type
- Small Molecule
- Chemical Formula
- C14H9Cl2N3S2
- CAS Number
- 187164-19-8
- Unique Ingredient Identifier
- RE91AN4S8G
Overview
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan.
Background
Luliconazole is a topical antifungal agent that acts by unknown mechanisms but is postulated to involve altering the synthesis of fungi cell membranes. It was approved by the FDA (USA) in November 2013 and is marketed under the brand name Luzu. Luliconazole is also approved in Japan.
Indication
Luliconazole is indicated for the treatment of interdigital tinea pedis, tinea cruris, or tinea corporis infections caused by Trichophyton rubrum and Epidermophyton floccosum.
Associated Conditions
- Tinea infections of the feet caused by Epidermophyton floccosum
- Tinea infections of the feet caused by Trichophyton rubrum
Clinical Trials
FDA Approved Products
Singapore Approved Products
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.